InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Sunday, 06/19/2016 6:30:36 PM

Sunday, June 19, 2016 6:30:36 PM

Post# of 2099
Thyroid Cancer Phase 2 study already met its primary endpoint of 6 month Progression Free Survival (“PFS”) with disease stabilization and safety, but we keep on following the patients for survival data, which we expect to report by the end of 2016.

They are releasing phase 2 data in a few months. And yes, if the data is good and they move to phase 3, expect another round of financing for thyroid ... like ovarian ... like rGBM. So trade accordingly.

https://www.sec.gov/Archives/edgar/data/1603207/000119312516589621/d185043d6k.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News